Continuing with our Pride Month podcast series, in this episode we speak with Perry Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, and James F. Dougherty, VMD, MS, current member of Rutgers' Board of Governors.
Rutgers University has a long track record of advocating for the LGBTQ+ community.
Image credit: Rutgers University
Welcome to another episode of Managed Care Cast and the second podcast in our series to celebrate Pride Month in 2024. In this episode, we speak with Perry Halkitis, PhD, MS, MPH, dean and Hunterdon Professor of Public Health & Health Equity at the Rutgers School of Public Health, and founder and director of the Center for Health, Identity, Behavior & Prevention Studies at Rutgers, and James F. Dougherty, VMD, MS, Rutgers’ alumnus, former chairman of the Board of Trustees of the university, and current member of its Board of Governors.
In December, Dougherty made a $3 million gift to the Rutgers School of Public Health that will help create the Institute for Sexual and Gender Minority Health at Rutgers and fund public policy research for the advocacy of, activism for, and attention on lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+) health, health care, and services.
He and Halkitis discuss Rutgers' long track record of advocating for the LGBTQ+ community, the importance of health care providers who are sensitive to the needs of these individuals, why LGBTQ pride should be celebrated year round, and empowering the community to always feel safe.
Listen above or through one of these podcast services:
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More